Meta AnalysisID 161

柴胡方剂治疗抗结核药物性肝损伤:一项系统评价与Meta分析

CRD42021262540

The aim of this meta-analysis of randomized controlled trials is to evaluate the efficacy and effectiveness of BC formula for the antituberculosis drug-induced hepatotoxicity.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
161
Evidence Id
8719
Core Evidence Id
8719
Source Meta Analysis Id
146
Herb2 Meta Analysis Id
HBMA000146
Crd Id
CRD42021262540
Title
Bupleurum chinense herbal formula for the antituberculosis drug-induced hepatotoxicity : A systematic review and meta-analysis
Review Question
The aim of this meta-analysis of randomized controlled trials is to evaluate the efficacy and effectiveness of BC formula for the antituberculosis drug-induced hepatotoxicity.
Study Type Included
Randomized controlled trials (RCTs) will be included.
Condition Being Studied
Tuberculosis (TB), as a global concern, seriously affects people's health. The WHO global tuberculosis report 2020 estimates that in 2019 10.0 million people fell ill with TB. Most of the first-line drugs used in the treatment of TB have potentially hepatotoxic effects. The standard short-course chemotherapy is an effective way to control TB, which includes a combination treatment of isoniazid , rifampicin, pyrazinamide, and ethambutol. Anti-TB chemotherapy often has a long course of treatment, and the combined use of multiple anti-TB medications has a heavier burden on the liver, which easily leads to patients being forced to stop treatment. Antituberculosis drug hepatotoxicity (ATDH), which makes it difficult for patients to adhere to the entire course of chemotherapy, is the most serious adverse effect of anti-tuberculosis therapy. As an ancient therapeutic method, Bupleurum chinense (BC, Radix Bupleuri) herbal formula has been used for thousands of years in China. Since the 1990s, there have been many clinical reports of BC formula for ATDH, and the curative effect is remarkable. However, There is a lack of systematic review on the BC formula for ATDH.
Participant
Inclusion criteria: Patients with liver injury after taking antituberculosis drugs. Gender and age are not limited. Exclusion criteria: Patients with other causes of liver injury or with underlying liver disease. Clinical data were lost or incomplete.
Animal
Human Disease Modelled
Intervention
Inclusion criteria: Patients were intervened with Bupleurum chinense (BC, Radix Bupleuri) herbal formula for intervention. Exclusion criteria: Patients were intervened by other ways except BC formula. (e.g. silybin, reduced glutathione)
Comparator Control
Inclusion criteria: Patients were intervened by other ways except BC formula. (e.g. silybin, reduced glutathione) Or stop using antituberculosis drugs, do not implement liver protection treatment. Exclusion criteria: Patients were intervened with Bupleurum chinense (BC, Radix Bupleuri) herbal formula for intervention.
Main Outcome
The total effective rate. Measures of effect RR
Outcome Measure
Additional Outcome
ALT(alanine aminotransferase), AST (aspartate aminotransferase) and TBil (total bilirubin). Measures of effect MD
Study Method
Meta-analysis, Systematic review
Keyword
Antitubercular Agents; Bupleurum; Bupleurum falcatum; Chemical and Drug Induced Liver Injury; Humans; Plants, Medicinal
Contact
ZHENG SHI [email protected]
Organisational Affiliation
Nanjing University of Chinese Medicine, Inst Literature Chinese Med http://yswx.njucm.edu.cn/
Funding Source
National Natural Science Foundation of China (NSFC) Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> 81904322
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Completed not published
First Submission Date
2021-06-23
Registration Date
2021-07-25
Anticipated Start Date
2021-06-22
Anticipated Completion Date
2021-07-23
Title Cn
柴胡方剂治疗抗结核药物性肝损伤:一项系统评价与Meta分析
Title En
Bupleurum chinense herbal formula for the antituberculosis drug-induced hepatotoxicity : A systematic review and meta-analysis
Bilingual Status
complete